MediDrink Platinum+ with a new fava bean protein and optional PeptiStrong to improve fitness in older adults with sarcopenia
Official title: Prospective, Open-Label, Multicenter Study to Characterise the Effects of Co-administration of MediDrink Platinum+ Formula Containing Novel Protein Blend SPR-01 and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
Run by Nuritas Ltd · NCT07322653 · Data updated 2026-11-12
This trial will see if MediDrink Platinum+ with a novel protein blend, given alone or together with PeptiStrong, improves fitness in malnourished adults aged 60 and older who have sarcopenia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Nuritas Ltd Industry-sponsored |
| Locations | 2 sites (Budapest and 1 other locations) |
| Status | Recruiting |
| Started | September 10, 2025 |
| Main results expected | October 1, 2026 |
| Study ends | January 2, 2027 |
| Registry record updated | January 7, 2026 |
| Trial ID | NCT07322653 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are ambulatory adults aged 60 or older who are malnourished (MNA < 11), have sarcopenia (SARC-F ≥ 4), a BMI ≤ 25 kg/m², can eat orally, and can provide informed consent.
✕Probably not a fit
Patients who cannot eat orally, have acute infection, intestinal obstruction, uncontrolled liver or renal failure, co-morbidities requiring special diets (e.g., uncontrolled diabetes or advanced kidney disease), recent use of certain supplements or metabolic steroids, or known intolerance to the products are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicentre, randomized active-control study enrolling 75 malnourished, sarcopenic adults aged 60+ using a 'Y' design where everyone starts on the base MediDrink Platinum formula for two weeks and then is randomized to receive the SRP-01 protein blend alone (n=37) or SRP-01 plus PeptiStrong (n=38) for 10 weeks. Dosing is individualized but provides at least 1200 kcal/day from the drink, with PeptiStrong dosed at 2.4 g/day when used. The primary outcome is change in general fitness measured by the Barthel Index, with secondary endpoints including hand-grip strength, the timed up-and-go test, and changes in fat-free body mass. The trial is sponsored by Nuritas Ltd in collaboration with Medifood Hungary and conducted at sites in Hungary.
Why it matters
Potential benefit: If successful, the intervention could improve daily functioning and muscle mass in malnourished older adults with sarcopenia, potentially lowering care needs and frailty.
How similar studies have gone: General protein supplementation has shown modest benefits for muscle mass and function in older adults, but the specific SRP-01 fava-bean blend and the PeptiStrong peptide combination are novel and not yet proven in large trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 60 years or older * BMI ≤ 25 kg/m² * Malnourished (mini nutritional assessment MNA \<11 * Sarcopenic: SARC-F score ≥ 4 * Capable or oral feeding either alone or assisted * Ambulatory (WHO PS/ECOG 0-3) * Ability to complete questionnaires and self assess health status * Ability to provide consent Exclusion Criteria: * Patient cannot eat orally * Acute Infection * Proven Intestinal obstruction * Co-morbidities requiring a special diet (diabetes, kidney disease etc.) * Liver dysfunction * Acute or chronic renal failure * Uncontrollable nausea or vomiting * Use of megestrol acetate or metabolic steroids * Dietary supplement use in the last 3 months * Known intolerance or allergy to the investigational products * Participation in any clinical trial within the last 3 months
Where it's running
-
Országos Korányi Pulmonológiai Intézet
Budapest, Hungary Recruiting -
Sóstói Szivárvány Idősek Otthona
Nyíregyháza, Hungary Recruiting
Study contacts
- Study coordinator: Edit Nadasi, MD, PhD
- Email: clinicaltrials@medifoodinternational.com
- Phone: +36 20 251 1762
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Movement and nutrition plan to prevent loss of function in older hospital patients
The study tests whether a supervised, personalized exercise program plus nutrition guidance can prevent declines in daily function for patients 65 and older during a hospital stay.
-
Egg white pudding supplement in care homes for sarcopenia in older adults
This study tests whether daily egg white pudding can help residents in personal care homes who receive dietary supplements and have sarcopenia, compared with a standard supplement.
-
Structured nutrition plus exercise to improve fat and muscle in older adults with obesity
This 12-week trial tests whether a supervised diet plan plus exercise improves fat mass and muscle function more than usual diet and exercise in adults aged 50 and older with obesity and insulin resistance.
-
Feeding-jejunostomy nutrition during pre-surgery treatment for esophagus or stomach cancer
This study tests whether giving nutrition through a jejunostomy tube during pre-surgery (neoadjuvant) treatment helps reduce complications after surgery for malnourished people with esophageal or stomach cancer.
-
Frame Running to Improve Exercise and Participation for Children and Young People With Physical Disabilities
This project will try a 24-week Frame Running training program to see if it improves function, participation, and quality of life in 8–18-year-olds with cerebral palsy or other physical disabilities.
-
Stability-focused breathing plus Kegel exercises for abdominal separation after cesarean
This test sees if adding stability-focused breathing exercises to Kegel routines helps postpartum women with abdominal separation, weaker core muscles, and lower back/pelvic pain after cesarean delivery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.